Red cell distribution width as a bleeding predictor after percutaneous coronary intervention.

[1]  L. Klein,et al.  Clinical ResearchInterventional Cardiology: Editorial CommentIs Patient Frailty the Unmeasured Confounder That Connects Subacute Stent Thrombosis With Increased Periprocedural Bleeding and Increased Mortality?⁎ , 2012 .

[2]  G. Lippi,et al.  The role of red blood cell distribution width in cardiovascular and thrombotic disorders , 2012, Clinical chemistry and laboratory medicine.

[3]  I. Kullo,et al.  Usefulness of red cell distribution width to predict mortality in patients with peripheral artery disease. , 2011, The American journal of cardiology.

[4]  Ewout W Steyerberg,et al.  Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers , 2011, Statistics in medicine.

[5]  K. Kent,et al.  Correlates and consequences of gastrointestinal bleeding complicating percutaneous coronary intervention. , 2010, The American journal of cardiology.

[6]  L. Afonso,et al.  Red cell distribution width and risk of coronary heart disease events. , 2010, The American journal of cardiology.

[7]  L. Ferrucci,et al.  Serum antioxidants and inflammation predict red cell distribution width in older women: the Women's Health and Aging Study I. , 2010, Clinical nutrition.

[8]  V. Chopra,et al.  Relation between red blood cell distribution width (RDW) and all-cause mortality at two years in an unselected population referred for coronary angiography. , 2010, International journal of cardiology.

[9]  S. Bandinelli,et al.  Red cell distribution width and mortality in older adults: a meta-analysis. , 2010, The journals of gerontology. Series A, Biological sciences and medical sciences.

[10]  W. Markiewicz,et al.  Relation between red cell distribution width and clinical outcomes after acute myocardial infarction. , 2010, The American journal of cardiology.

[11]  G. Lippi,et al.  Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. , 2009, Archives of pathology & laboratory medicine.

[12]  J. Marmur,et al.  Red cell distribution width (RDW) as a predictor of long-term mortality in patients undergoing percutaneous coronary intervention , 2009, Thrombosis and Haemostasis.

[13]  Sunil V. Rao,et al.  Bleeding in Patients Undergoing Percutaneous Coronary Intervention: The Development of a Clinical Risk Algorithm From the National Cardiovascular Data Registry , 2009, Circulation. Cardiovascular interventions.

[14]  L. Ferrucci,et al.  Red blood cell distribution width and the risk of death in middle-aged and older adults. , 2009, Archives of internal medicine.

[15]  Fang-Shu Ou,et al.  Trends in the prevalence and outcomes of radial and femoral approaches to percutaneous coronary intervention: a report from the National Cardiovascular Data Registry. , 2008, JACC. Cardiovascular interventions.

[16]  M. Bell,et al.  Major femoral bleeding complications after percutaneous coronary intervention: incidence, predictors, and impact on long-term survival among 17,901 patients treated at the Mayo Clinic from 1994 to 2005. , 2008, JACC. Cardiovascular interventions.

[17]  E. Ribeiro,et al.  A randomized trial of 5 versus 7 French guiding catheters for transfemoral percutaneous coronary stent implantation. , 2008, Journal of interventional cardiology.

[18]  B. Davis,et al.  Relation Between Red Blood Cell Distribution Width and Cardiovascular Event Rate in People With Coronary Disease , 2008, Circulation.

[19]  Adelaide,et al.  Bivalirudin for patients with acute coronary syndromes. , 2006, The New England journal of medicine.

[20]  E. Topol,et al.  Economic evaluation of bivalirudin with provisional glycoprotein IIB/IIIA inhibition versus heparin with routine glycoprotein IIB/IIIA inhibition for percutaneous coronary intervention: results from the REPLACE-2 trial. , 2004, Journal of the American College of Cardiology.

[21]  Werner Klein,et al.  Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE) , 2003 .

[22]  E. Topol,et al.  Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial. , 2003, JAMA.

[23]  Edward G Lakatta,et al.  Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease Enterprises: Part III: Cellular and Molecular Clues to Heart and Arterial Aging , 2003, Circulation.

[24]  L. Fried,et al.  Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. , 2002, Archives of internal medicine.

[25]  K. Eagle,et al.  Predictors of length of stay after coronary stenting. , 2001, American heart journal.

[26]  K. Anstrom,et al.  Contemporary outcome trends in the elderly undergoing percutaneous coronary interventions: results in 7,472 octogenarians. National Cardiovascular Network Collaboration. , 2000, Journal of the American College of Cardiology.

[27]  C J Knight,et al.  Altered platelet function detected by flow cytometry. Effects of coronary artery disease and age. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[28]  P M Mannucci,et al.  Hypercoagulability in centenarians: the paradox of successful aging. , 1995, Blood.

[29]  M. Pencina,et al.  Red cell distribution width is a predictor of mortality in patients undergoing percutaneous coronary intervention , 2012, Journal of Thrombosis and Thrombolysis.

[30]  Y. Wen.  High red blood cell distribution width is closely associated with risk of carotid artery atherosclerosis in patients with hypertension. , 2010, Experimental and clinical cardiology.